- Home
- FRHC vs JAZZ Comparison
FRHC vs JAZZ Comparison
Compare FRHC & JAZZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FRHC
- JAZZ
- Stock Information
- Founded
- FRHC 1981
- JAZZ 2003
- Country
- FRHC Kazakhstan
- JAZZ Ireland
- Employees
- FRHC N/A
- JAZZ N/A
- Industry
- FRHC Investment Bankers/Brokers/Service
- JAZZ Biotechnology: Pharmaceutical Preparations
- Sector
- FRHC Finance
- JAZZ Health Care
- Exchange
- FRHC Nasdaq
- JAZZ Nasdaq
- Market Cap
- FRHC 7.2B
- JAZZ 8.1B
- IPO Year
- FRHC N/A
- JAZZ 2007
- Fundamental
- Price
- FRHC $146.11
- JAZZ $136.01
- Analyst Decision
- FRHC
- JAZZ Strong Buy
- Analyst Count
- FRHC 0
- JAZZ 14
- Target Price
- FRHC N/A
- JAZZ $177.50
- AVG Volume (30 Days)
- FRHC 104.1K
- JAZZ 705.2K
- Earning Date
- FRHC 02-07-2025
- JAZZ 02-25-2025
- Dividend Yield
- FRHC N/A
- JAZZ N/A
- EPS Growth
- FRHC N/A
- JAZZ 458.10
- EPS
- FRHC 5.36
- JAZZ 7.04
- Revenue
- FRHC $1,578,152,000.00
- JAZZ $3,992,712,000.00
- Revenue This Year
- FRHC N/A
- JAZZ $7.53
- Revenue Next Year
- FRHC N/A
- JAZZ $6.94
- P/E Ratio
- FRHC $27.28
- JAZZ $19.33
- Revenue Growth
- FRHC 79.07
- JAZZ 5.23
- 52 Week Low
- FRHC $64.00
- JAZZ $99.06
- 52 Week High
- FRHC $164.83
- JAZZ $138.27
- Technical
- Relative Strength Index (RSI)
- FRHC 49.94
- JAZZ 68.46
- Support Level
- FRHC $148.41
- JAZZ $134.56
- Resistance Level
- FRHC $157.60
- JAZZ $138.27
- Average True Range (ATR)
- FRHC 6.13
- JAZZ 3.56
- MACD
- FRHC -0.65
- JAZZ 1.17
- Stochastic Oscillator
- FRHC 28.61
- JAZZ 88.20
About FRHC Freedom Holding Corp.
Freedom Holding Corp is a holding company with its subsidiary it is engaged in securities brokerage, securities dealing for customers and account, market-making activities, investment research, investment counseling, investment banking services, retail and commercial banking, insurance products, payment services, and information processing services. It acts as a professional participant through its subsidiaries on the Kazakhstan Stock Exchange (KASE), Moscow Exchange (MOEX), Saint-Petersburg Exchange (SPB), the Ukrainian Exchange, the Uzbek Republican Currency Exchange (UZCE), and the Republican Stock Exchange of Tashkent (UZSE). Its segments are Brokerage, Banking, Insurance, and Others.
About JAZZ Jazz Pharmaceuticals plc (Ireland)
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.